dark spots eraser pen

Manufacturer
Guangzhou Kadiya Biotechnology Co., Ltd.
Effective date
2025-08-01
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-06-01 01:09:20

Label at a glance#

Productdark spots eraser pen
Active ingredientSALICYLIC ACID, KOJIC ACID
Label structure8 sections

Label contents#

Full prescribing information#

OTC - PURPOSE SECTION

For whitening, Moisturizing, Antioxidant

INACTIVE INGREDIENT SECTION

Water
Butylene Glycol
4-Butylresorcinol
Phragmites Communis Extract
Glycyrrhiza Uralensis (licorice)Root Extract
Cornus OfficinalisFruit Extract
SuperoxideDismutase
Morinda Citrifolia FruitExtract
Sodium Hyaluronate
Sodium Poly Glutamate
Panthenol
Lactic Acid
Allantoin
PropyleneGlycol
Methylparaben
GlycerylCaprylate
CaprylhydroxamicAcid

WARNINGS SECTION

Warning.

1、For external use only, avoid contact with eyes when used

2、Keep out of reach of children

INDICATIONS & USAGE SECTION

Formulated with intensive, comprehensive skintone correcting technology including our powerful anti-irritant boosting compound and advanced anti-spot ingredient, 4-Butylresorcinol, Kojic Acid, Lactic Acid, Salicylic Acid, and Morinda Citrifolia extract, this Dark Spots Eraser Pen is the essential core of the Enlighten regimen, It works wonders for both Men and Women of all skin types and is vegan, cruelty-free, and gluten-free.

DOSAGE & ADMINISTRATION SECTION

Formulated with intensive, comprehensive skintone correcting technology including our powerful anti-irritant boosting compound and advanced anti-spot ingredient, 4-Butylresorcinol, Kojic Acid, Lactic Acid, Salicylic Acid, and Morinda Citrifolia extract, this Dark Spots Eraser Pen is the essential core of the Enlighten regimen, It works wonders for both Men and Women of all skin types and is vegan, cruelty-free, and gluten-free.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

KEEP OUT OF REACH OF CHILDREN SECTION

OTC - ACTIVE INGREDIENT SECTION

Active Ingredients
Kojic acid1.2%
SalicylicAcid2%

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Active Ingredients
Kojic acid1.2%
SalicylicAcid2%
Uses:
For whitening, Moisturizing, Antioxidant
The storage method:
Store sealed in a cool place and out of sunlight
Warning.
1、For external use only, avoid contact with eyes when used
2、Keep out of reach of children
Water
Butylene Glycol
4-Butylresorcinol
Phragmites Communis Extract
Glycyrrhiza Uralensis (licorice)Root Extract
Cornus OfficinalisFruit Extract
SuperoxideDismutase
Morinda Citrifolia FruitExtract
Sodium Hyaluronate
Sodium Poly Glutamate
Panthenol
Lactic Acid
Allantoin
PropyleneGlycol
Methylparaben
GlycerylCaprylate
CaprylhydroxamicAcid

erasereraser

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
f52be47f-7aa7-46c0-b1fa-50c18dd50206Product name120201029
444b3e50-f226-46ef-bfca-2e7035d140cdProduct name120190611
dea2eded-d1e7-46bb-9a3d-f8dc20de6277Product name120190408
7cda52fc-125f-421c-8fea-bc1974370c49Product name220180703
597b1cfd-7b31-5048-62be-ca5cd740da2fProduct name120140508
ec2149b3-5c6d-5344-f757-c86411073075Product name120140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
84423-087-01dark spots eraser pen20 g in 1 BOTTLE, GLASSSOLUTION, CONCENTRATE201

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 20 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
84423-08784423-087-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 19 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
3b592682-0e5f-d02e-e063-6294a90a41ca3b592682-0e5e-d02e-e063-6294a90a41ca2025-08-01WarningsExact identifier
spl id: 3b592682-0e5f-d02e-e063-6294a90a41ca
spl set id: 3b592682-0e5e-d02e-e063-6294a90a41ca

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.